Monocyte chemoattractant protein-1 (MCP-1) gene transduction: an effective tumor vaccine strategy for non-intracranial tumors

Cancer Immunology Immunotherapy

Volumn 41, Issue 4, 1995, Pages 227-235

  Manome, Yoshinobu ^a   Wen, Patrick Y ^b   Hershowitz, Ari ^a   Tanaka, Toshihide ^a   Rollins, Barrett J ^a   Kufe, Donald W ^a   Fine, Howard A ^a  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

9L gliosarcoma model; Malignant glioma; MCP 1; Tumor vaccine

Indexed keywords

CANCER VACCINE; MONOCYTE CHEMOTACTIC PROTEIN 1;

ANIMAL CELL; ARTICLE; BRAIN TUMOR; CHO CELL; CONTROLLED STUDY; GENETIC TRANSDUCTION; GLIOSARCOMA; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMAL; BRAIN NEOPLASMS; GENETIC ENGINEERING; GLIOSARCOMA; HUMAN; MALE; MICE; MONOCYTE CHEMOATTRACTANT PROTEIN-1; NEOPLASM TRANSPLANTATION; RATS; RATS, INBRED F344; RECOMBINANT PROTEINS; SKIN; SKIN NEOPLASMS; TRANSFECTION; TUMOR CELLS, CULTURED; VACCINES, SYNTHETIC;

EID: 0028824705     PISSN: 03407004     EISSN: 14320851     Source Type: Journal    
DOI: 10.1007/BF01516997     Document Type: Article

References (46)

1. Expression of murine interleukin 7 in a murine glioma cell line results in reduced tumorigenicity in vivo
2. Efficient catheter-mediated gene transfer into the heart using replication-defective adenovirus
3. Glioblastoma mutliforme: a controlled trial to assess the value of specific active immunotherapy in patients treated by radical surgery and radiotherapy
4. Autologous glioma transplantation
5. Immunosuppression and transforming growth factor-β in glioblastoma. Preferential production of transforming growth factor-β2
6. Monocyte chemotactic ctyokine gene transfer modulates macrophage infiltration, growth, and susceptibility to IL-2 therapy of a murine melanoma
7. Monocyte chemoattractant protein 1 acts as a T-lymphocyte chemoattractant
8. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease
9. Number and evolutionary conservation of α and β tubulin and cytoplasmic β and γ-actin genes using specified cloned cDNA probes
10. Cytokine gene transfer in tumor inhibition and tumor therapy: where are we now?
11. Regression of bladder tumors in mice treated with interleukin-2 gene-modified tumor cells
12. Human astrocytomas and glioblastomas express monocyte chemoattractant protein-1 (MCP-1) in vivo and in vitro
13. Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colongy-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity
14. Biochemical and biologic characterization of murine monocyte chemoattractant protein-1. Identification of two functional domains
15. Nervous tissue as an immune compartment: the dialect of the immune response in the CNS
16. Interleukin 2 gene transfer into tumor cells abrogates tumorigenicity and induces protective immunity
17. Treatment of established renal cancer by tumor cells engineered to secrete interleukin-4
18. Tumor autograft response in patients with glioblastoma multiforme
19. Mechanisms of rejection induced by tumor cell-targeted gene transfer of interleukin 2, interleukin 4, interleukin 7, tumor necrosis factor, in interferon γ
20. Generation of cytotoxic immune responses during the progression of a rat glioma
21. Role of bone marrow-derived cells in presenting MHC class 1-restricted tumor antigens
22. Immunotherapy of malignant gliomas
23. Monocyte chemoattractant protein-1 regulates adhesion molecule expression and cytokine production in human monocytes
24. An improved rat brain-tumor model
25. Inhibition of lymphocyte function by glioblastoma-derived transforming growth factor β2
26. Quantitative study of monocyte chemoattractant protein-1 (MCP-1) in cerebrospinal fluid and cyst fluid from patients with malignant glioma
27. Immunobiology of malignant astrocytomas
28. Molecular basis of the immune response to neural antigens
29. Contemporary approaches to the treatment of malignant gliomas with radiation therapy
30. Immunobiology of primary intracranial tumors. Part 7: Active immunization of patients with anaplastic human glioma cells: a pilot study
31. Alterations in signal transduction molecules in T lymphocytes from tumor-bearing mice
32. Immunotherapy with cytokine gene-transduced tumor cells: the next wave in gene therapy for cancer
33. Cancer vaccines
34. Antimetastatic vaccination of tumor-bearing mice with two types of IFN-gamma gene-inserted tumor cells
35. Suppression of tumor formation in vivo by expression of the JE genen in malignant cells
36. Cloning and expression of JE, a gene inducible by platelet-derived growth factor and whore product has cytokine-like properties
37. Human tumor vaccines and genetic engineering of tumors with cytokine and histocompatibility genes to enhance immunogenicity
38. Biology of the RANTES/SIS cytokine family
39. Gene therapy of rat 9L gliosarcoma tumors by transduction with selectable genes does not require durg selection
40. Experimental and clinical studies of cytokine gene-modified tumor cells
41. Murine interleukin-4 displays potent antitumor activity in vivo
42. Tumor rejection after direct costimulation of CD8+ T cells by B7-1 transfected melanoma cells
43. Immunotherapy of prostate cancer in the Dunning rat model: use of cytokine gene modified tumor vaccines
44. Exogenous expression of mouse interferon gamma cDNA in mouse neuroblastoma C1300 cells results in reduced tumorigenicity by augmented anti-tumor immunity
45. Clinical experience with immunotherapy
46. Treatment of glioma by engineered interleukin 4-secreting cells